ABBREVIATIONS 3D-TOF = 3D time of flight; CI = confidence interval; DSA = digital subtraction angiography; EVT = endovascular treatment; FSE = fast spin-echo; HRMRI = high-resolution MRI; IMH = intramural hematoma; MRA = MR angiography; OR = odds ratio; TSE = turbo spin-echo; VBDA = vertebrobasilar dissecting aneurysm. SUBMITTED September 20, 2016 Department of Neurosurgery, the First Affiliated Hospital, Nanchang University, Nanchang, Jiangxi Province, China OBJECTIVE The recurrence rate of vertebrobasilar dissecting aneurysms (VBDAs) after reconstructive endovascular treatment (EVT) is relatively high. The aneurysm wall enhancement on high-resolution MRI (HRMRI) reportedly predicts an unsteady state of an intracranial aneurysm. The authors used HRMRI to investigate the relationship between wall enhancement on HRMRI and progression of VBDAs after reconstructive EVT. METHODS From January 2012 to December 2015, patients with an unruptured VBDA who underwent reconstructive EVT were enrolled in this study. Preoperative enhanced HRMRI was performed to evaluate radiological characteristics. The relationships between aneurysm wall enhancement and various potential risk factors were statistically analyzed. Follow-up angiographic examination was performed with digital subtraction angiography and conventional HRMRI. Cox regression analysis was performed to identify predictors of VBDA progression after reconstructive EVT. RESULTS Eighty-two patients (12 women and 70 men, mean age 53.48 ± 9.23 years) with 83 VBDAs were evaluated in the current study. The average maximum diameter of the VBDAs was 11.30 ± 7.90 mm. Wall enhancement occurred in 43 VBDAs (51.81%). Among all 83 VBDAs, 62 (74.70%) were treated by stent-assisted coil embolization and 21 (25.30%) by stenting alone. The mean duration of imaging follow-up among all 82 patients was 10.55 months (range 6-45 months), and 15 aneurysms (18.07%) exhibited progression. The statistical analysis indicated no significant differences in age, sex, risk factors (high blood pressure, smoking, diabetes mellitus, and a high cholesterol level), VBDA stage, or VBDA size between enhanced and unenhanced VBDAs. Univariate Cox regression analysis showed that both the maximum diameter of the VBDAs and wall enhancement were associated with recurrence (p < 0.05). Multivariate Cox proportional hazard regression analysis showed that the maximum diameter of the VBDAs and wall enhancement on HRMRI were independent risk factors for aneurysm progression (p < 0.05). CONCLUSIONS Aneurysm size and wall enhancement on HRMRI can predict the progression of VBDAs after reconstructive EVT.
S pontaneouS intracranial dissecting aneurysms are rare. 2 However, East Asian populations demonstrate a higher incidence of these types of aneurysms. 14 The incidence rate may have increased due to the development of diagnostic technology. 13 Intracranial vertebrobasilar dissecting aneurysms (VBDAs) are the most common type of intracranial dissecting aneurysms.
14 Endovascular treatment (EVT) is now the most common operative meth-od for treating VBDAs. 11 Reconstructive EVT, an important type of EVT, still faces some challenges such as a relatively high recurrence rate. 12 Identifying risk factors that may lead to VBDA progression after reconstructive EVT and taking appropriate measures to improve the efficacy of reconstructive EVT have become important issues.
High-resolution MRI (HRMRI) has been widely used to diagnose VBDAs. 4, 15 Wall enhancement of a saccular aneurysm on HRMRI is a proven sign of inflammatory change and might predict an unsteady state of an intracranial saccular aneurysm. 5, 9 However, few studies have focused on wall enhancement of VBDAs. We hypothesized that wall enhancement might also predict an unsteady state of a VBDA as well as its progression after reconstructive EVT. In this study we used 3-T black-blood HRMRI to investigate the relationship between VBDA wall enhancement and aneurysm progression after reconstructive EVT, and we performed multivariate Cox proportional hazard regression analysis to identify risk factors that may lead to VBDA progression after reconstructive EVT.
Methods

Study Population
After obtaining IRB approval, we prospectively enrolled consecutive patients with unruptured VBDAs from January 2012 to December 2015. Digital subtraction angiography (DSA), MR angiography (MRA), and MRI were used to diagnose the intracranial dissecting aneurysms. An intracranial dissecting aneurysm was diagnosed when MRA or DSA showed fusiform dilation of vessels or the pearl-and-string sign or when MRI showed intimal flaps, the double-lumen sign, or an intramural hematoma (IMH). Patients planning to undergo reconstructive EVT underwent enhanced HRMRI examinations before EVT if they had no contraindication for enhanced HRMRI. The inclusion criteria were adult patients (age 18-80 years), our expectation of adequate patient safety during the examination, patients' willingness to participate in the study, and patients' ability to cooperate during the MRI examination. The exclusion criteria were the absence of radiological follow-up and a history of deconstructive EVT. Informed consent was obtained from each patient prior to the MRI examination. The VBDA stages were classified as acute (0-3 days), early subacute (3-10 days), late subacute (10-60 days), and chronic (> 60 days) according to the time interval from symptom onset as described in previously published studies. 3, 10 Patient baseline information including age, sex, comorbidities (hypertension, diabetes, hyperlipidemia), smoking, and stages of VBDAs were recorded.
HRMRI and Vessel Wall Imaging Assessment
High-resolution MR images were obtained with two 3-T MRI machines using 8-channel head coils at each site. The scan parameters are shown in Table 1 . T1-and T2-weighted images were obtained using fast spin-echo (FSE) sequences (Signa TwinSpeed, GE Healthcare) or turbo spin-echo (TSE) sequences (Magnetom Trio [Tim System], Siemens Healthcare). For each site, 3D time-offlight (3D-TOF) imaging was performed first to locate the aneurysm. Fat-and blood-suppressed, thin-slice T2-and T1-weighted images covering the site of each lesion were then obtained. Fat-saturation technique was applied for all sequences except for 3D-TOF imaging. Quartic or double inversion recovery sequences were used in T1-weighted imaging. Axial plane images were acquired for all postcontrast T1-weighted images 5 minutes after Gd injection (0.1 mmol/kg gadopentetate dimeglumine, Magnevist; Bayer Schering Pharma AG) using parameters identical to those of the precontrast T1-weighted images.
Two experienced radiologists (each with 10 years of experience in vascular neuroimaging) blinded to the clinical data independently reviewed the images. The VBDA was first identified on the TOF image. Two-dimensional shortaxis images of the aneurysm generated from pre-and postcontrast T1-weighted images were used to identify wall enhancement. The wall enhancement was defined as complete enhancement when the entire aneurysm wall was enhanced after contrast agent infusion; otherwise, it was defined as partial enhancement when only part of the aneurysm wall was enhanced. The degree of enhancement was assessed based on a visual grading system as follows: Grade 0, not enhanced; Grade 1, similar to that of normal vessel walls but less than that of muscle; and Grade 2, similar to or greater than that of muscle. 10 Disagreements were resolved by a third radiologist with 15 years of experience in vascular neuroimaging. The maximum diameter of each VBDA at the level of the lesion's largest diameter was measured on HRMRI, including both the dilated aneurysm and the IMH if present.
General Protocol for Reconstructive EVT
At our institute, patients with unruptured VBDAs with an obvious mass effect are treated as soon as possible if they can tolerate EVT. The first-choice operation for these patients is internal trapping if collateral blood supply is sufficient, while stent-assisted coil embolization or sole stenting is a viable alternative. However, patients with unruptured VBDAs and no obvious mass effect were initially evaluated with MRI/MRA and treated conservatively. If the dissection site was shown to be continuously enlarged on follow-up MRI or MRA, or if the symptoms (e.g., ischemic events) recurred, angiography was performed to further evaluate the lesion. Reconstructive or deconstructive EVT was then scheduled after a risk/benefit evaluation for selected patients. The stent-assisted coiling reconstructive technique was selected for lesions with an apparent dilation requiring coil embolization, while stenting alone was selected for lesions without enough space for coil embolization after stent placement.
Endovascular procedures were performed while patients were under general anesthesia. Patients were premedicated with a dual antiplatelet regimen (75 mg of clopidogrel and 100 mg of aspirin daily) for 5 days before the operation. Both antiplatelet agents were given orally once daily for 6 weeks after the procedure. Following this treatment, 100 mg of aspirin daily was continued for the next 6 months. Platinum coils were used to embolize the aneurysms, and self-expanding neurovascular stents were used to reconstruct the entire dissected segment.
The various embolic materials used during EVT included detachable coils such as the Matrix coil (Cordis) and Microplex coil (MicroVention). Self-expanding neurovascular stents such as the Enterprise stent (Cordis Neurovascular), Solitaire AB stent (ev3), and Low-Profile Visualized Intraluminal Support Device (MicroVention) were used to reconstruct the dissected artery. The metal coverage of the Solitaire and Enterprise stents is 7.22% and 11.89% in 3-mm vessels and 5.42% and 8.92% in 4-mm vessels, respectively. 8 The average metal coverage of the Low-Profile Visualized Intraluminal Support stent is approximately 23.00% in 3-4-mm vessels according to its product description.
Angiography Assessment
The DSA findings were reviewed by 2 experienced interventional neuroradiologists, each with 10 years of experience in interventional neuroradiology, and disagreements were resolved by a third radiologist with 15 years of experience in interventional neuroradiology. EVT details including treatment modality, immediate obliteration grade, type of stents used, and important branches involved were recorded, as were angiographic follow-up outcomes. The immediate obliteration grade was defined as complete obliteration if the aneurysmal sac was not visualized after the endovascular procedure, and partial obliteration if contrast agent was still present in the aneurysmal sac. The important vessel branches were the posterior inferior cerebellar artery, anterior inferior cerebellar artery, superior cerebellar artery, posterior cerebral artery, anterior spinal artery, or other large perforating arteries.
Radiological Follow-Up
Lifelong radiological follow-up was recommended for patients in this study. At approximately 6 months, followup DSA was performed to observe the reconstruction outcome of the vessel lumen and conventional HRMRI (T1-weighted imaging, T2-weighted imaging, and 3D-TOF MRA) was performed mainly to observe the change in the size of the lesions after treatment. However, enhanced T1-weighted imaging was not routinely recommended for follow-up MRI because the signal of the artery wall (especially for lesions without an obvious IMH) was susceptible to metal artifacts associated with the stents and coils after EVT. If the lesion was confirmed to be stable on DSA, the patient was then followed up annually with conventional HRMRI. If the lesion was confirmed to be recurrent on DSA and a second EVT was performed, then follow-up angiographic examination was performed using DSA and conventional HRMRI approximately 6 months after the second treatment. Until the lesion was confirmed to be stable on DSA, the patient was followed up annually by conventional HRMRI. The last follow-up time (for stable cases) and the follow-up period during which lesion progression was first confirmed (for progression cases) were recorded and set as the end point in the Cox regression.
Aneurysm progression was defined as either aneurysm recurrence on DSA or enlargement of the external diameter of an aneurysm; otherwise, the lesion was considered stable. Angiographic recurrence was defined as a substantial increase in the contrast medium-filled portion of the dissecting aneurysm compared with a control angiogram taken immediately after the initial treatment. 7 The 3 maximum external diameters of each VBDA on axial, coronal, and sagittal MR images at the level of the lesion's largest diameter were measured on both pretreatment and follow-up MR images. The external diameter of a VBDA included both the dilated aneurysm and the IMH if present. External diameter enlargement was defined as either ≥ 2.0-mm growth in at least 1 direction among the maximum axial, coronal, and sagittal diameters or ≥ 1.0-mm growth in 2 directions among the maximum axial, coronal, and sagittal diameters.
Statistical Analysis
Patient age and the maximum diameter of the dissecting aneurysm are presented as means and standard deviations. The 1-sample Kolmogorov-Smirnov test was used to identify normally distributed variables. One-way ANOVA or the Mann-Whitney U-test was used to investigate the relationship between wall enhancement and potential risk factors. Univariate analysis of factors, including the characteristics of the patients and aneurysms, was performed to determine the association of aneurysm progression with other potential risk factors. Variables with a p value < 0.05 in the univariate analysis were candidates for inclusion in the multivariate Cox proportional hazard regression. All data processing and statistical analyses were performed using SPSS (version 22.0, IBM Corp.). Statistical significance was defined as p < 0.05. 
Results
In total, 82 patients (12 women and 70 men) with 83 aneurysms were enrolled in this study; 1 patient had 2 aneurysms. The mean age of the patients was 53.48 ± 9.23 years. The mean maximum diameter of the VBDAs was 11.30 ± 7.90 mm. Wall enhancement (Grade 1 and Grade 2) was observed in 43 VBDAs (51.80%) in this study (Table 2). The wall enhancement was partial in 33 VBDAs (76.74%) and complete in 10 (23.36%). An IMH was present in 48 VBDAs (57.83%; Table 3 ). One significant characteristic of the VBDAs with a larger IMH was the occurrence of subacute bleeding in the circumferential part of the IMH, which is not connected to the lumen and was rarely enhanced, while the intimal flap and the IMH close to the lumen were usually enhanced. The stent-assisted coiling reconstructive technique was used in 62 VBDAs (74.70%) and sole stenting in 21 VBDAs (25.30%). Angiographic follow-up was performed for a mean of 10.55 months (range 6-45 months). Aneurysm progression was observed in 15 VBDAs (18.07%) and stability in 68 VBDAs (81.93%; Table 3 ).
Relationship Between Wall Enhancement and Potential
Influencing Factors
According to the degree of VBDA wall enhancement, the patients were allocated to either the enhancement group (Grades 1 and 2) or no-enhancement group (Grade 0). The aneurysm size was 28.06% larger in the enhancement group than in the no-enhancement group, although the difference did not reach statistical significance (p = 0.11). The Mann-Whitney U-test also showed no significant differences in age, sex, risk factors, or VBDA stages (the period from onset to MRI performance) between the 2 groups ( Table 2) .
Results of Radiographic Follow-Up and Risk Factors for Aneurysm Progression
The aneurysm progression and risk factors among all 83 VBDAs are shown in Table 3 . Univariate Cox analysis showed that both maximum diameter of the VBDAs and wall enhancement were associated with recurrence (p < 0.05). Although the rates of complete obliteration and metal coverage were higher in the stable group than in the progression group (28% vs 20%, and 20.88% vs 20.72%, respectively), neither of them could predict lesion progression according to univariate analysis (p > 0.05). None of the other factors could predict lesion progression according to univariate analysis either (p > 0.05). Multivariate Cox analysis showed that both maximum diameter of the VBDA and wall enhancement were independent risk factors for aneurysm progression (p < 0.05). VBDAs with a small maximum diameter had a lower rate of progression (odds ratio [OR] 1.05, 95% confidence interval [CI] 1.00-1.10). Compared with VBDAs with enhancement Grade 0, VBDAs with enhancement Grade 1 had a significantly higher rate of lesion progression (OR 8.96, 95% CI 1.03-78.25; p = 0.04); VBDAs with enhancement Grade 2 also had a significantly higher rate of lesion progression (OR 9.90, 95% CI 1.19-82.22; p = 0.03).
Eight patients also received enhanced HRMRI followup (4 progression cases and 4 stable cases). The 4 patients with progression, whose aneurysms were all recurrent on DSA, all showed an enlargement of the external diameter on follow-up HRMRI. Both the pretreatment and followup HRMRI of the 4 patients with progression showed wall enhancement (Grade 1 or Grade 2). The 4 stable patients, whose aneurysms were confirmed to be completely occluded on follow-up DSA, had no change in size of the lesions on follow-up HRMRI. Both the pretreatment and follow-up HRMRI of the 4 stable patients showed no wall enhancement (Grade 0) or mild wall enhancement (Grade 1).
Discussion
In the present study, aneurysm wall enhancement on HRMRI before EVT and a larger aneurysm size were more frequently observed in progressive (e.g., Figs. 1-3 ) than stable VBDAs (e.g., Fig. 4 ) after reconstructive EVT.
Many studies have investigated the risk factors for recurrence of VBDAs after reconstructive EVT. 1, 7, 16 These reported risk factors include aneurysm size, patient age, stent number, and immediate obliteration grade of the aneurysm sac. 1, 7, 16 However, few of these studies included the stability of the arterial wall as a risk factor. VBDA is more likely to represent a disease of the vessel wall than a disease of the vessel lumen. 2 Instability of the vessel wall (e.g., due to inflammation) may play an important role in the recurrence of VBDAs after reconstructive EVT. Therefore, we included wall enhancement as an indicator and found that wall enhancement and aneurysm size were independent predictors of a high aneurysm progression rate.
Many observations indicate that aneurysm wall enhancement can be used as an indirect marker of vessel wall inflammation and therefore as a potential marker of aneurysm instability. 5, 9 Hu et al. 5 found evidence of inflammation of the aneurysm wall through pathological studies and proved that aneurysm wall enhancement on HRMRI is highly consistent with pathological changes of inflammation. According to a report by Iihara et al. 6 regarding resection of a VBDA with a huge IMH, pathological evidence of inflammatory cell infiltration was present in the IMH.
The detailed mechanism of wall enhancement and the factors that influence this phenomenon remain unknown. The aneurysm size was larger in the enhancement group than in the no-enhancement group in the present study, although this difference did not reach statistical significance. According to a study of cervical artery dissection by Habs and colleagues, 3 the signal intensity of the dissecting wall varies over time; however, our study proves that there is no significant relationship between the signal intensity of the dissecting wall and the period from onset to MRI performance. One possible explanation for this difference is that our study included a limited number of samples and most of patients had a late subacute or chronic stage VBDA.
The results of this study may be useful for clinical practice. First, enhancement HRMRI, which is noninvasive, reproducible, and assessable by the naked eye without postprocessing, is an easy means of predicting the prognosis of VBDAs before treatment. In VBDAs equally suitable for observation or EVT, wall enhancement on HRMRI may guide management toward more prompt intervention. Second, our findings can remind interventional neuroradiologists to pay close attention to VBDAs with wall enhancement and take prompt action to embolize the aneurysm densely and improve the stent metal coverage in the aneurysm neck, therefore improving the efficacy of EVT. Using the case in Figs. 1-3 as an example, valuable information can be obtained from retrospective analysis of the patient's HRMRI findings before EVT and the DSA findings at the time of the first EVT. The first site of recurrence (Fig. 3A) , where the intimal flap and IMH near the lumen were obviously enhanced on HRMRI, was embolized with only loose coils. At the second site of recurrence (Fig. 3A) , where the vessel wall near IMH was also enhanced on HRMRI, the 3 Enterprise stents used in the first operation may not have been long enough to cover the whole dissecting artery. These may be the reasons for the repeated recurrences. The aneurysm size was also found to be an independent predictor of aneurysm progression, with larger aneurysms associated with a higher progression rate. This finding has been reported by many authors. 16 Large VBDAs, which are believed to develop from small, unstable VBDAs, might be even less stable than small VBDAs. Additionally, large VBDAs generally have a longer dissecting segment and aneurysm neck, making them difficult to completely occlude. These might be the reasons for the association between larger aneurysms and higher progression rates after reconstructive EVT.
The obliteration grade of the aneurysm and metal coverage of the stent in the aneurysm neck were believed to be important factors for a low aneurysm recurrence rate after reconstructive EVT. 16 In this study, the rates of both complete obliteration and metal coverage were higher in the stable group than that in the progression group, although the difference was not statistically significant. However, we still think the 2 factors were important for aneurysm recurrence after reconstructive EVT, and we always strive to achieve dense embolism of the aneurysm and high metal coverage of the stent in the aneurysm neck (e.g., overlapping stents) in our clinical practice. The limited number of cases from a single institution might explain why these 2 factors were excluded from the risk factors for aneurysm progression in the multivariate Cox proportional hazard regression analysis.
Limitations to the Study
There are some limitations to this study, such as patient selection bias and limited number of cases from a single institution. The follow-up period may be not long enough for some cases and a longer follow-up period was needed to verify the conclusion. The enhancement grading system based on observation only in this study may not be sufficiently objective to avoid artificial error. The progression of VBDAs after reconstructive EVT is a complex process that can be influenced by many factors, but the Cox regression model in this study cannot include all risk factors. The aneurysms were heterogeneous (e.g., differences in treatment modality, follow-up interval, embolic material, aneurysm configuration, and potentially underlying pathology) and these may be confounding factors in this study. Additionally, flow diverter stents were not used in this study because the Pipeline embolization device (ev3) became available in our institute in October 2015, and we also began treating VBDAs with this device after obtaining IRB approval in July 2016. The cases treated by the Pipeline embolization device were not included in this study because of the limited number of patients and lack of angiographic follow-up. A further study is needed to evaluate patients who have been treated with flow-diverting devices to verify the conclusions in the present study.
Conclusions
Wall enhancement on HRMRI might predict an unsteady state of VBDAs. Aneurysm size and wall enhance- 
FIG. 3.
The causal analysis for aneurysm recurrences on DSA and HRMRI. The patient represented by these images is the same patient as in Figs. 1 and 2 . Anteroposterior view of the left vertebral angiogram (A) on DSA after the first EVT and the coronary T2-weighted HRMRI image (B) before EVT of the same patient in Figs. 2 and 3 . The first recanalization site was embolized using only loose coils (circle) and the second recanalization site was not well covered by stents (square; proximal stent markers can be seen), which may be the potential reasons for the 2 recanalizations. ment on HRMRI can predict the progression of VBDAs after reconstructive EVT. These findings can remind interventional neuroradiologists to pay close attention to large VBDAs with wall enhancement on MRI and take prompt action in endovascular procedures, in turn improving the efficacy of EVT.
